Cited by 14Sarcoma Diagnosis and TreatmentNeutrophil, Myeloperoxidase and Oxidative MechanismsCancer Immunotherapy and Biomarkers

Osteosarcoma neutrophil extracellular trap network-associated gene recurrence and metastasis model

Open access
Tang, Hao, Xie, Jiang, Du, Yu-Xuan, Tan, Ze-Jiu, Liang, Zhuo-Tao·2024·Journal of Cancer Research and Clinical Oncology

Abstract

Osteosarcoma (OS) is the most common malignancy in children and adolescents and has a high probability of recurrence and metastasis. A growing number of studies have shown that neutrophil extracellular traps (NETs) are strongly associated with cancer metastasis, but in osteosarcoma, genes associated with NETs that promote osteosarcoma recurrence and metastasis remain to be explored. We systematically investigated the gene expression patterns of NETs in OS samples from the GEO database. NETs molecular typing was evaluated based on NETs expression profiles, and the association between NETs molecular subtypes and immune microenvironment and metastatic features were explored. Ultimately, we constructed a signature model and column line graph associated with metastasis prediction and screened possible potential drugs for metastatic osteosarcoma. We established two different molecular subtypes of NETs, which showed significant differences in metastatic status, metastasis time, tumor immune microenvironment, and biological effects. We also constructed a NETs-related gene metastasis signature(NRGMS) to assess the expression pattern of NETs in patients to predict metastatic recurrence in osteosarcoma patients. We screened for TOMM40 and FH associated with metastatic recurrence in osteosarcoma patients. Overall, this study constructs a predictive model for osteosarcoma metastasis of NETs-related genes, which is expected to provide new insights into the metastasis of osteosarcoma.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00432-023-05577-2

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In osteosarcoma, a signature derived from NETs is associated with tumor recurrence and metastasis, and can predict patient prognosis.

    “In osteosarcoma, a signature derived from NETs is associated with tumor recurrence and metastasis, and can predict patient prognosis [41, 42].”

    From Advances on immunotherapy for osteosarcoma (2024) · cites this paper as [42]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Kamihara J, Schultz KA, Rana HQJG: FH tumor predisposition syndrome. 2020. 20301430

Cited by

Sorted by citations

Authors
Tang, H., Xie, J., Du, Y.-X., Tan, Z.-J., & Liang, Z.-T.
Affiliations
Central South University (CN)
Corresponding author
Liang, Zhuo-Tao
Venue
Journal of Cancer Research and Clinical Oncology
Published
2024-01-29
Volume
150
Issue
2
Pages
48-48
ISSN
  • 0084-5353 (ISSN-L)
  • 1432-1335
OpenAlex
W4391305176
Cited by
14
References
41
Citations by year
2026: 6 · 2025: 3 · 2024: 5
FWCI
4.07
Type
journal article
Language
en
Open access
Locations
  • Journal of Cancer Research and Clinical Oncology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Fundamental Research Funds for the Central Universities of Central South University.
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Sarcoma Diagnosis and Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
osteosarcoma, neutrophil extracellular traps, tumor recurrence, metastasis prediction, tumor immune microenvironment, molecular subtypes, TOMM40, familial hypercholesterolemia, drug screening, pediatric bone cancer
MeSH terms
Adolescent, Bone Neoplasms, Child, Humans, Osteosarcoma, Databases, Factual, Neoplasms, Second Primary, Tumor Microenvironment, Extracellular Traps

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review